Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,302,616
-
Share change
-
-908,525
-
Total reported value
-
$24,524,657
-
Price per share
-
$2.17
-
Number of holders
-
64
-
Value change
-
-$5,120,736
-
Number of buys
-
40
-
Number of sells
-
21
Institutional Holders of Metagenomi, Inc. - COM (MGX) as of Q3 2024
As of 30 Sep 2024,
Metagenomi, Inc. - COM (MGX) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,302,616 shares.
The largest 10 holders included
Novo Holdings A/S, RA CAPITAL MANAGEMENT, L.P., FARALLON CAPITAL MANAGEMENT LLC, PFM Health Sciences, LP, CITADEL ADVISORS LLC, HHLR ADVISORS, LTD., Sozo Ventures GP II, L.P., BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.